Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Werewolf Therapeutics, Inc. | Chief Operating Officer | Stock Option (right to buy) | 93.6K | Jan 3, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HOWL | Werewolf Therapeutics, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 9, 2023 | Chief Operating Officer |
HOWL | Werewolf Therapeutics, Inc. | Jan 6, 2022 | 1 | $0 | 4 | Jan 18, 2022 | Chief Operating Officer |
HOWL | Werewolf Therapeutics, Inc. | Dec 30, 2021 | 2 | $22K | 4 | Jan 4, 2022 | Chief Operating Officer |
HOWL | Werewolf Therapeutics, Inc. | Dec 15, 2021 | 2 | -$40.2K | 4 | Dec 17, 2021 | Chief Operating Officer |